Bonus Sessions

Join GI physicians from the U.S. and around the world for the virtual ACG Annual Scientific Meeting. ACG 2020 will deliver the latest clinical information on timely topics in gastroenterology and hepatology.

NEW for ACG 2020! We have added an ACG All Access Pass, combine the three ACG Friday courses with the Postgraduate Course and the Annual Meeting plus the two bonus sessions (formerly the Learning Lunches and Breakfast Sessions) and save 20 percent! Register for any two courses and save up to 10 percent!

Bonus Sessions (Formerly Breakfast Sessions) - Must be registered for the Annual Scientific Meeting and purchase access to these sessions.
Session A: Clinical Challenges in Acute and Chronic Pancreatitis
  • Evaluation and Management of Acute Recurrent Pancreatitis
    Santhi Swaroop Vege, MD, MACG
    Outline the definition, diagnosis, and evaluation of the patient with ARP, including the indications and roles of endoscopic, medical, and surgical treatments.
  • A Practical Multidisciplinary Approach to the Diagnosis and Management of Chronic Pancreatitis
    Tyler Stevens, MD, FACG
    Summarize the indications and roles of medical, endoscopic, and surgical management of CP, including pain management.
  • Management of Acute Necrotizing Pancreatitis in 2020: An Update
    Prabhleen Chahal, MD, FACG
    Discuss the evidence-based, multidisciplinary and state of the art approach to management of the patient with severe necrotizing pancreatitis.
Session B: IBD: The Latest and Greatest In…
  • …Efficacy
    David P. Hudesman, MD
    Analyze up-to-date evidence, including comparative effectiveness, of biologic and small molecule efficacy in IBD.
  • …Safety
    Raymond K. Cross, Jr., MD, MS, FACG
    Recognize current safety concerns for biologics and small molecules used to treat IBD.
  • …Emerging Therapies
    Bincy P. Abraham, MD, FACG
    Identify promising therapeutics for the treatment of IBD.
Session C: Hot Topics in Liver Disease
  • Management of Cirrhotic Complications
    Mitchell A. Mah’moud, MD, FACG
    Discuss the current strategies for high quality management of HE, ascites, and complications of end stage liver disease.
  • AKI in Cirrhotics
    Paul Y. Kwo, MD, FACG
    Describe the current definition of acute kidney injury (AKI) in cirrhotics and identify the strategies to prevent and treat.
  • Alcoholic Liver Disease
    Mark W. Russo, MD, MPH, FACG
    Identify the epidemiology of alcoholic liver disease, current management, and future therapies.
Session D: Symptoms Following Foregut Interventions: It’s Back in Your Court
  • Reflux and Recurrent Dysphagia After Achalasia Interventions
    Rena H. Yadlapati, MD, MSHS
    Formulate a treatment strategy for patients who remain symptomatic after intervention for achalasia.
  • Dysphagia, Dyspepsia, and Bloating After Anti-Reflux Surgery
    Scott L. Gabbard, MD
    Manage dysphagia and functional gastrointestinal symptoms after antireflux surgery.
  • Weight Lost, Symptoms Gained: Complaints After Bariatric Surgery
    Violeta B. Popov, MD, PhD, FACG
    Identify and manage common patient concerns after bariatric surgery.
Session E: Innovations in Practice Management
  • Social Media and Your Practice: The Why and How
    Mark B. Pochapin, MD, FACG
    Discuss benefits and risks of having a social media presence for your practice and how to establish one, including creating a website and handling patient reviews.
  • Telemedicine and Your Practice: Is It Worth It?
    Jordan J. Karlitz, MD, FACG
    Describe infrastructure, settings, coding, reimbursement, and the specific experience/advantage for hepatology and IBD, especially in underserved areas.
  • APPs and Your Practice: Maximizing Their Potential While Providing Quality Care
    Daniel J. Pambianco, MD, FACG
    Identify the role of APPs in various practice and specialty settings, how to train APPs, utilizing various billing scenarios, and how to make it profitable.
Session F: Colonic Conundrums
  • Pseudo-Obstruction – Update on Management
    Mariam Naveed, MD
    Summarize the current practice standards for diagnosis and management of pseudo-obstruction of the colon.
  • Know When to Stent ‘em and When to Cut ‘em: Managing Malignant Obstruction
    Amrita Sethi, MD
    Identify when to stent versus when to operate in malignant colorectal obstruction.
  • Acute and Recurrent Diverticulitis – To Cut or Not to Cut
    Susan Galandiuk, MD, FACG, FACS, FASCRS
    Discuss the updated guidelines for treatment of acute and recurrent diverticulitis and when to operate.
Session G: Minimizing and Managing Endoscopic Complications: Tips and Tricks from the Experts
  • Endoscopic Resection
    Amit Bhatt, MD
    Describe management of complications associated with EMR, ESD, EFTR and STER procedures.
  • ERCP/EUS
    Shivangi T. Kothari, MD, FACG
    Discuss management of common and uncommon complications in ERCP and EUS.
  • Endoscopic Complication Pot-pourri
    Patrick I. Okolo, III, MD, MPH
    Identify the various types of endoscopic complications and their optimal management.
Session H: When GI Meets Surgery in IBD – The Severe UC Patient
  • Steroid Refractory UC
    Jimmy K. Limdi, MD, FACG
    Describe treatments available for steroid refractory ulcerative colitis.
  • Time to Meet the Surgeon
    Jean H. Ashburn, MD
    Discuss key components of the surgical consultation in medically refractory ulcerative colitis.
  • Back to the GI – J-Pouch Complications
    Shannon Chang, MD
    Categorize common complications arising in patients with ileal pouch-anal anastomosis.
Session I: Recent ACG Liver Guidelines
  • Vascular Disorders of the Liver
    Patrick S. Kamath, MD
    Distinguish the different vascular disorders of the liver and recognize management strategies.
  • Hemochromatosis
    Vinay Sundaram, MD
    Evaluate patients for iron overload and describe treatment plans.
  • Alcoholic Liver Disease
    Ashwani K. Singal, MD, MS, FACG
    Explain the different aspects of alcoholic liver disease and summarize the latest guideline recommendations.
Session J: 2020 Hindsight: Where We Have Been and Where We Are Going
  • High-Quality Endoscopic Mucosal Resection: When and How
    Christina J. Tofani, MD
    Discuss the appropriate use of EMR, provide practical pearls, and demonstrate the techniques used for EMR.
  • I Should Have Seen It Coming! Preventing and Managing Polypectomy Complications
    Douglas K. Rex, MD, MACG
    Explain how to decrease complications of polypectomy, including tips regarding cautery, snares, and prophylactic clipping, and how to manage bleeding and perforations.
  • Today and Tomorrow: Technological Advances That Matter
    Seth A. Gross, MD, FACG
    Identify the hot technology of today and what is around the corner that could change the practice of GI and quality metrics.
Session K: Hey, It’s Legal Now: Cannabinoids and the Gut
  • Cannabinoid Effects on Motility and Pain
    Ron Schey, MD, FACG
    Differentiate various effects of cannabinoids on the gastrointestinal tract.
  • Cannabinoids: Friend or Foe in Nausea and Vomiting?
    Thangam Venkatesan, MD
    Contrast risk and benefits of cannabinoids in patients with chronic nausea and vomiting.
  • It’s High Time We Learn How to Talk to Patients About Cannabis
    Linda Anh B. Nguyen, MD
    Formulate an approach to the discussion of cannabinoids in patients with gastrointestinal symptoms.
Session L: Management Strategies for Eosinophilic Esophagitis
  • Medical Management: PPI and Steroid Therapy
    Jennifer Horsley-Silva, MD
    Identify the benefits of each individual approach to therapy in EoE: PPI, topical steroids, or both.
  • Dietary Management: Two, Four or Six Food Elimination?
    Nirmala Gonsalves, MD
    Describe the benefits and burden of different food elimination diets in the management of EOE.
  • Management of Refractory EoE
    Evan S. Dellon, MD, MPH, FACG
    Define refractory EoE and describe potential alternative therapies/approaches to control disease.
Session M: FMT
  • How to Introduce FMT Into Your Practice – Formulation, Administration, and Regulation
    Neilanjan Nandi, MD
    Explain the how to’s involved in setting up FMT in a GI practice.
  • The Science Behind the Stool
    Jessica R. Allegretti, MD, MPH
    Identify clinically relevant information for the practicing gastroenterologist regarding how FMT works, potential side effects, precautions, and how this applies to managing patients.
  • Current and Future Indications for FMT
    Colleen R. Kelly, MD, FACG
    Discuss current and speculate future uses of FMT.
Session N: Reproduction in IBD: From Conception to Postpartum
  • Fertility and Conception: It Takes Two!
    Shayla A. Schoenoff, PA
    Discuss common fertility and preconception concerns for men and women with IBD.
  • Pregnancy: The Three Trimesters
    Eugenia Shmidt, MD
    Describe the management of IBD during pregnancy and delivery.
  • Postpartum: The Fourth Trimester
    Lisa B. Malter, MD, FACG
    Outline challenges of IBD treatment in the postpartum period, including lactation, resumption of therapy, and infant vaccinations.
Session O: Fundamentals of Quality Liver Care
  • Updates in Viral Hepatitis
    Joseph C. Ahn, MD, MS, MBA, FACG
    Distinguish between the different viral hepatitides and identify the best management options.
  • Preop Management of Patients With Liver Disease
    Mitchell L. Shiffman, MD, FACG (VA)
    Describe best practices for preoperative management of patients with liver disease.
  • Noninvasive Evaluation of Fibrosis
    Michael F. Chang, MD
    Compare the latest options on noninvasive evaluation of hepatic fibrosis and understand how to choose the between the options.